Mallalieu, Navita L. http://orcid.org/0000-0002-7203-6307
Wimalasundera, Sunethra
Hsu, Joy C.
Douglass, Wendy
Wells, Chris
Penades, Inmaculada Calvo
Cuttica, Ruben
Huppertz, Hans-Iko
Joos, Rik
Kimura, Yukiko
Milojevic, Diana
Rosenkranz, Margalit
Schikler, Kenneth
Constantin, Tamas
Wouters, Carine
Funding for this research was provided by:
F. Hoffmann-La Roche Ltd (N/A)
Article History
Received: 7 June 2019
Accepted: 14 August 2019
First Online: 22 August 2019
Ethics approval and consent to participate
: This study was conducted in accordance with the principles of the Declaration of Helsinki and Good Clinical Practice and was approved by the appropriate institutional review boards and/or ethics committees. Written informed consent to participate in the study was obtained from the patients’ parents or legal guardians.
: Not applicable.
: NLM – Employee of Roche, owns shares in Roche.SW – Employee of Roche.JCH – Employee of Roche, owns share in Roche.WD – Employee of Roche, owns shares in Roche.CWells – Employee of Roche, owns shares in Roche.ICP – Research grants to institution from Roche.RC – Consultant and speaker for Roche, Novartis, Lilly, GlaxoSmithKline, Bristol Myers Squibb, Janssen.H-IH – None.RJ – None.YK – Salary support from CARRA; research grant from Genentech.DM – None.MR – None.KS – Research grant support from SOBI and CARRA.TC – None.CWouters – Research grants to institution from GlaxoSmithKline, Pfizer, Roche